04:07p | MODERNA : Biden Administration Officials Told Governors They Will Increase Weekl.. | DJ |
03:56p | ASTRAZENECA : EU contract did not leave time to fix vaccine hiccups - AstraZenec.. | RE |
03:34p | ASTRAZENECA : working on vaccine with Oxford to target new variant, CEO says -La.. | RE |
02:54p | Pfizer working on booster shot to protect against COVID-19 variants | RE |
02:32p | ROCHE HOLDINGS AG : Goldman Sachs maintains a Buy rating | MD |
01:46p | Johnson & Johnson's Profit Is Boosted by Pharmaceuticals Business -- 2nd Upda.. | DJ |
01:22p | MODERNA : Biden administration to purchase millions more vaccine doses to curb v.. | RE |
01:18p | ASTRAZENECA : Italy asks EU to take action against Pfizer over COVID-19 vaccine .. | RE |
01:15p | China ambassador says export delays for Brazil vaccine supplies not political | RE |
01:09p | Sanofi to help produce 100 million Pfizer/BioNTech vaccine doses | RE |
01:00p | Sanofi to help produce 100 mln Pfizer/BioNTech vaccine doses | RE |
12:48p | GAVI seeks political support for COVAX as rich nations strike fresh vaccine d.. | RE |
12:10p | EU drugs agency says it is offering advice to makers of Russian vaccine | RE |
11:13a | MEIRAGTX : AAV-CNGA3 Gets FDA Fast-Track Designation in Achromatopsia | DJ |
11:04a | REGENERON PHARMACEUTICALS : Antibody Drug Temporarily Protects Against Covid-19,.. | DJ |
10:30a | Who's a good doggy? Martha Stewart launches cannabis pet products | RE |
09:42a | NOVO NORDISK : Goldman Sachs keeps its Buy rating | MD |
09:14a | Clydesdales Charge Into a Super Bowl Ad After All -- for Sam Adams | DJ |
09:03a | Johnson & Johnson's Profit Is Boosted by Pharmaceuticals Business --Update | DJ |
08:20a | Johnson & Johnson Profit Is Boosted by Pharmaceuticals Business | DJ |
08:13a | MYOVANT SCIENCES : Pfizer Report Positive Results From Relugolix Trial | DJ |
07:43a | ASTRAZENECA : Astra offers small concession, EU pleads for UK-made shots amid va.. | RE |
07:27a | JOHNSON & JOHNSON : Expects Growth in 2021 Sales, Adjusted Profit | DJ |
07:23a | ELI LILLY AND : Lilly Sees Bamlanivimab, Etesevimab Reduce Covid-19 Risks | DJ |
07:22a | NOVARTIS AG : Gets a Buy rating from UBS | MD |
07:18a | MERCK : European Commission Approves Keytruda in Some Colorectal Cancers | DJ |
07:16a | JOHNSON & JOHNSON : Posts 4Q Profit, Growth in Pharma Sales | DJ |
07:12a | PFIZER : Israel Offers Glimpse of a World Vaccinated From Covid-19 | DJ |
07:00a | ASTRAZENECA : offers EU earlier COVID-19 vaccine supplies in Feb, no clarity on .. | RE |
06:52a | ASTRAZENECA : UBS reiterates its Neutral rating | MD |
06:43a | GLAXOSMITHKLINE : Berenberg Keeps GSK at Buy, Trims Target | MT |
06:13a | NOVARTIS AG : Morgan Stanley reiterates its Buy rating | MD |
06:08a | ASTRAZENECA : offers EU earlier supplies in Feb but no clarity on rerouting from.. | RE |
05:59a | GLAXOSMITHKLINE : Deutsche Bank sticks Neutral | MD |
05:43a | NOVARTIS AG : Kepler Cheuvreux sticks Neutral | MD |
05:33a | NOVARTIS : Bryan Garnier & Co Lifts Price Target on Novartis, Maintains Buy Reco.. | MT |
05:21a | NOVARTIS AG : Buy rating from Goldman Sachs | MD |
04:56a | NOVARTIS : CEO renews commitment to Sandoz generics unit | RE |
04:05a | NOVARTIS : regulatory delays add to pandemic sales hit | RE |
03:33a | NOVARTIS AG : Jefferies reaffirms its Buy rating | MD |
03:33a | GLAXOSMITHKLINE : Berenberg keeps its Buy rating | MD |
03:31a | HIKMA PHARMACEUTICALS : Says It Is in Talks With GlaxoSmithKline to Buy Some Bus.. | DJ |
02:53a | NOVO NORDISK : JP Morgan gives a Buy rating | MD |
02:46a | Germany backs EU export restrictions on vaccine after supply cuts | RE |
02:41a | ASTRAZENECA : COVID-19 vaccine supplies continue to be tight, UK minister says | RE |
02:33a | ASTRAZENECA : Symbicort Approved in China for Mild Asthma | DJ |
02:21a | SHIONOGI : Japan's Shionogi sells coronavirus drug rights to U.S. biotech BioAge | RE |
01:51a | SHIONOGI : Japan's Shionogi sells coronavirus drug rights to U.S. biotech BioAge | RE |
01:43a | NOVARTIS : 4Q Profit, Sales Grew | DJ |
01:14a | ASTRAZENECA : German minister says EU will base decision on AstraZeneca vaccine .. | RE |